Dr. (Nick) Goeders is a native of Shreveport who grew up surrounded by addiction in the form of alcoholism, which affected both of his parents. He also lost a close friend and college roommate due to an overdose on pain pills.
Dr. Goeders received his Ph.D. in Pharmacology in 1984. He received postgraduate training in Neuroscience at The Johns Hopkins University School of Medicine before returning to the Department of Pharmacology, Toxicology & Neuroscience at the LSU Health Sciences Center in Shreveport, in 1985. He has been the Head of the Department since 2005.
Dr. Goeders has investigated the neurobiology involved in the interplay between stress and addiction for the past 30 years, and his research has been funded by the National Institute on Drug Abuse (NIDA) at NIH throughout his career, starting when he was in graduate school. He has published over 100 scientific papers, several book chapters, and he has been invited to discuss his research at scientific meetings and institutions throughout the world. He holds two patents based on his work.
Dr. Goeders is a co-founder of Embera NeuroTherapeutics, Inc., a specialty biopharmaceutical company focused on developing treatments for cocaine use disorder, tobacco use disorder, and other addictions, for which there are a limited range of effective drug therapies or no approved treatment options. Dr. Goeders' research led to the founding of Embera.
Dr. Goeders has served on the Board of Directors for the College on Problems of Drug Dependence (CPDD) and is a member of many other professional societies, including the Society for Neuroscience. Locally, he is on the Board of Directors for the Council on Alcoholism & Drug Abuse of Northwest Louisiana (CADA).